These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 25134439)
21. In vitro and in vivo characterization of ultraviolet light C-irradiated human platelets in a 2 event mouse model of transfusion. Zhi L; Chi X; Vostal JG PLoS One; 2013; 8(11):e79869. PubMed ID: 24224014 [TBL] [Abstract][Full Text] [Related]
22. Immune modulation and lack of alloimmunization following transfusion with pathogen-reduced platelets in mice. Jackman RP; Muench MO; Heitman JW; Inglis HC; Law JP; Marschner S; Goodrich RP; Norris PJ Transfusion; 2013 Nov; 53(11):2697-709. PubMed ID: 23451715 [TBL] [Abstract][Full Text] [Related]
23. Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light. Fryk JJ; Marks DC; Hobson-Peters J; Watterson D; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Faddy HM Transfusion; 2017 Nov; 57(11):2677-2682. PubMed ID: 28718518 [TBL] [Abstract][Full Text] [Related]
33. Effect of increased agitation speed on pathogen inactivation efficacy and in vitro quality in UVC-treated platelet concentrates. van der Meer PF; Gravemann U; de Korte D; Sumian C; Tolksdorf F; Müller TH; Seltsam A Vox Sang; 2016 Aug; 111(2):127-34. PubMed ID: 27167507 [TBL] [Abstract][Full Text] [Related]
34. Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light. Faddy HM; Fryk JJ; Prow NA; Watterson D; Young PR; Hall RA; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC Transfusion; 2016 Jun; 56(6 Pt 2):1548-55. PubMed ID: 26926832 [TBL] [Abstract][Full Text] [Related]
35. Hypothermic storage of leukoreduced red blood cells for greater than 21 days is a safe alternative to irradiation. Mykhailova O; Turner TR; Olafson C; Howell A; Nahirniak SN; Wizniak J; Gerges HYN; Baldwin T; Clarke G; Acker JP Transfusion; 2021 Apr; 61(4):1247-1257. PubMed ID: 33481275 [TBL] [Abstract][Full Text] [Related]
36. Pathogen reduction with riboflavin and ultraviolet light induces a quasi-apoptotic state in blood leukocytes. Tran JQ; Muench MO; Heitman JW; Jackman RP Transfusion; 2019 Nov; 59(11):3501-3510. PubMed ID: 31599981 [TBL] [Abstract][Full Text] [Related]
37. Flow path system of ultraviolet C irradiation from xenon flash to reduce bacteria survival in platelet products containing a platelet additive solution. Abe H; Endo K; Shiba M; Niibe Y; Miyata S; Satake M Transfusion; 2020 May; 60(5):1050-1059. PubMed ID: 32187695 [TBL] [Abstract][Full Text] [Related]
38. Preserved functional and biochemical characteristics of platelet components prepared with amotosalen and ultraviolet A for pathogen inactivation. Hechler B; Ohlmann P; Chafey P; Ravanat C; Eckly A; Maurer E; Mangin P; Isola H; Cazenave JP; Gachet C Transfusion; 2013 Jun; 53(6):1187-200. PubMed ID: 23067365 [TBL] [Abstract][Full Text] [Related]
39. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model. Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119 [TBL] [Abstract][Full Text] [Related]
40. Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light. Faddy HM; Fryk JJ; Hall RA; Young PR; Reichenberg S; Tolksdorf F; Sumian C; Gravemann U; Seltsam A; Marks DC Transfusion; 2019 Jul; 59(7):2223-2227. PubMed ID: 31050821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]